These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1052 related articles for article (PubMed ID: 33983525)

  • 1. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study.
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Le Bon SD; Saussez S; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):811-816. PubMed ID: 33983525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients.
    Vaira LA; Deiana G; Lechien JR; De Vito A; Cossu A; Dettori M; Del Rio A; Saussez S; Madeddu G; Babudieri S; Fois AG; Cocuzza C; Hopkins C; De Riu G; Piana AF
    Laryngoscope; 2021 Oct; 131(10):2312-2318. PubMed ID: 34287905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.
    Saussez S; Sharma S; Thiriard A; Olislagers V; Vu Duc I; Le Bon SD; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR; Vaira LA; Marchant A
    Eur J Neurol; 2021 Nov; 28(11):3702-3711. PubMed ID: 34157187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia.
    Sanli DET; Altundag A; Kandemirli SG; Yildirim D; Sanli AN; Saatci O; Kirisoglu CE; Dikensoy O; Murrja E; Yesil A; Bastan S; Karsidag T; Akinci IO; Ozkok S; Yilmaz E; Tuzuner F; Kilercik M; Ljama T
    Am J Otolaryngol; 2021; 42(1):102796. PubMed ID: 33152573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Effects on Psychophysical Olfactory Scores: Prospective Study With Evaluation Before and 60-Days After Infection.
    Vaira LA; Lechien JR; Salzano G; Maglitto F; Boscolo-Rizzo P; Hopkins C; De Riu G
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1249-1252. PubMed ID: 36821798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6.
    Cazzolla AP; Lovero R; Lo Muzio L; Testa NF; Schirinzi A; Palmieri G; Pozzessere P; Procacci V; Di Comite M; Ciavarella D; Pepe M; De Ruvo C; Crincoli V; Di Serio F; Santacroce L
    ACS Chem Neurosci; 2020 Sep; 11(17):2774-2781. PubMed ID: 32786309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients.
    Vaira LA; Hopkins C; Petrocelli M; Lechien JR; Soma D; Giovanditto F; Rizzo D; Salzano G; Piombino P; Saussez S; De Riu G
    J Otolaryngol Head Neck Surg; 2020 Aug; 49(1):56. PubMed ID: 32762737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
    Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing olfactory dysfunction in acute and recovered COVID-19 patients: a single center study in Italy.
    Pasquini J; Maremmani C; Salvadori S; Silani V; Ticozzi N
    Neurol Sci; 2021 Jun; 42(6):2183-2189. PubMed ID: 33768438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.
    Boscolo-Rizzo P; Menegaldo A; Fabbris C; Spinato G; Borsetto D; Vaira LA; Calvanese L; Pettorelli A; Sonego M; Frezza D; Bertolin A; Cestaro W; Rigoli R; D'Alessandro A; Tirelli G; Da Mosto MC; Menini A; Polesel J; Hopkins C
    Chem Senses; 2021 Jan; 46():. PubMed ID: 33575808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
    Lechien JR; Chiesa-Estomba CM; De Siati DR; Horoi M; Le Bon SD; Rodriguez A; Dequanter D; Blecic S; El Afia F; Distinguin L; Chekkoury-Idrissi Y; Hans S; Delgado IL; Calvo-Henriquez C; Lavigne P; Falanga C; Barillari MR; Cammaroto G; Khalife M; Leich P; Souchay C; Rossi C; Journe F; Hsieh J; Edjlali M; Carlier R; Ris L; Lovato A; De Filippis C; Coppee F; Fakhry N; Ayad T; Saussez S
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2251-2261. PubMed ID: 32253535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of patient recognition of coronavirus disease 2019 (COVID-19)-associated olfactory loss and recovery: a longitudinal study.
    Prajapati DP; Shahrvini B; Said M; Srinivas S; DeConde AS; Yan CH
    Int Forum Allergy Rhinol; 2021 Nov; 11(11):1529-1537. PubMed ID: 34096193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19.
    Haehner A; Draf J; Dräger S; de With K; Hummel T
    ORL J Otorhinolaryngol Relat Spec; 2020; 82(4):175-180. PubMed ID: 32526759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The temporal course of COVID-19 anosmia and relation to other clinical symptoms.
    Altundag A; Saatci O; Sanli DET; Duz OA; Sanli AN; Olmuscelik O; Temirbekov D; Kandemirli SG; Karaaltin AB
    Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1891-1897. PubMed ID: 33237475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan.
    Cheng MY; Hsih WH; Ho MW; Lai YC; Liao WC; Chen CY; Chen TC; Lee YL; Liu PY; Kao CC; Chou CH; Lin PC; Chi CY; Leong LY; Tai CJ; Lu MC
    J Microbiol Immunol Infect; 2021 Oct; 54(5):794-800. PubMed ID: 33610511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by Retronasal Olfactory Testing.
    Hirano K; Tanaka Y; Kamimura S; Suzaki I; Suzuki E; Kobayashi H
    Am J Case Rep; 2022 Sep; 23():e936496. PubMed ID: 36089753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.